ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Singapore-based Tikva raised an US$8 million Series A round. The company targets solid cancer barriers with its technology. The funding will support further development of its approach against solid tumors.
Tap to vote and see what everyone thinks.
Summary by ByteBrief